Ashfield Engage, a business unit of UDG Healthcare’s Ashfield, has acquired life science consultancy Nuvera for $36 million.

Following the acquisition, Nuvera, headquartered in New Jersey, will become part of Ashfield Engage, a global partner in customer strategy and execution. Ashfield will integrate Nuvera’s patient-support offerings into its own services, which span medical affairs, market access, commercial and event experiences.

Ten-year-old Nuvera has about 20 employees and works with more than 15 pharmaceutical clients across more than 24 therapeutic areas, according to its website. The consulting firm focuses on the rare disease and specialty therapeutics spaces, with a concentration in designing and executing HCP- and patient-support programs.

“By leveraging the strategic and operational insight of both organizations, we will be able to bring our program implementation experience to the table earlier and influence the overall strategic direction of patient support,” said Ashfield Engage’s Nareda Mills, global president, patient solutions, in a statement.

Nuvera founder and managing partner Greg Klein said that becoming part of Ashfield Engage, which has a wider breadth of engagements and worldwide footprint, “will lead to an overall greater impact for our clients and their patients.”

Klein will report to Mills, and Nuvera will continue to operate as a separate brand as part of the Ashfield Engage Patient Solutions offering.

Ashfield Engage is one business unit of Ashfield, alongside Ashfield Advisory and Ashfield Health. Earlier this year, the Ashfield companies rebranded into the three units, and Ashfield Health also streamlined into seven agency brands, tapping McCann Health vet Amar Urhekar to lead the organization.

This story has been updated with additional information on the Nuvera deal, as well as added clarity on Ashfield’s organizational structure.